Description of Business and Summary of Significant Accounting Policies (Details Narrative) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 20, 2026 |
Jul. 22, 2026 |
Sep. 12, 2025
USD ($)
$ / shares
shares
|
Sep. 30, 2026
USD ($)
$ / shares
|
Jun. 30, 2026
USD ($)
|
Mar. 31, 2026
USD ($)
|
Sep. 30, 2025
USD ($)
|
Jun. 30, 2025
USD ($)
|
Mar. 31, 2025
USD ($)
|
Sep. 30, 2026
USD ($)
Segment
$ / shares
shares
|
Sep. 30, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
$ / shares
|
|
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||
| Research and development expense | $ 2,983,773 | |||||||||||
| Reverse stock split, description | 1-for-20 | a 1-for-20 Reverse Stock Split of the Company’s issued and outstanding common stock, which became effective on August 20, 2026. At the effective time, every 20 shares of common stock were automatically converted into one share, with fractional shares rounded up to the nearest whole share. The Reverse Stock Split was effected to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. | 1-for-20 | |||||||||
| Net loss | $ 2,815,597 | $ 3,290,970 | $ 3,150,228 | $ 954,059 | $ 60,346 | $ 137,583 | $ 9,256,795 | $ 1,151,988 | ||||
| Cas in operating activities | 3,393,445 | 9,627,048 | ||||||||||
| Cash and cash equivalents | 1,579,689 | 1,579,689 | ||||||||||
| Accumulated deficit | 14,104,350 | 14,104,350 | 4,847,555 | |||||||||
| Prepaid research and development | 314,783 | 314,783 | $ 6,166,294 | |||||||||
| Prepaid R&D balance | 265,682 | 265,682 | ||||||||||
| FDIC insured amount | $ 250,000 | $ 250,000 | ||||||||||
| Common stock, par value | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||||||
| Net proceeds | $ 15,655,192 | |||||||||||
| Number of operating segment | Segment | 1 | |||||||||||
| Number of reportable segment | Segment | 1 | |||||||||||
| IPO [Member] | ||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||
| Number of shares issued, shares | shares | 187,500 | |||||||||||
| Common stock, par value | $ / shares | 0.0001 | $ 0.0001 | ||||||||||
| Sale of stock price per share | $ / shares | $ 80.00 | $ 80.00 | ||||||||||
| Gross proceeds | $ 15,000,000.0 | |||||||||||
| Net proceeds | 2,120,000 | |||||||||||
| Underwriting discounts and commissions | 1,410,000 | |||||||||||
| Other offering related expenses | $ 710,000 | 710,000 | ||||||||||
| Net proceeds | $ 13,240,000 | |||||||||||
| Over-Allotment Option [Member] | ||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||
| Number of shares issued, shares | shares | 28,125 | |||||||||||
| Sale of stock price per share | $ / shares | $ 80.00 | |||||||||||
| Gross proceeds | $ 2,250,000 | |||||||||||
| Underwriting discounts and commissions | 180,000 | |||||||||||
| Net proceeds | $ 2,070,000.00 | |||||||||||
| X | ||||||||||
- Definition Other offering related expenses. No definition available.
|
| X | ||||||||||
- Definition Prepaid R&D balance. No definition available.
|
| X | ||||||||||
- Definition Underwriting discounts and commissions. No definition available.
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's first offering of stock to the public. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|